4 completed, 1 recruiting. 2 Not applicable, 2 Phase 4, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Recruiting 1 |
| Phase 4 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow James Lewis: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Healthy Volunteers Enteral Nutrition Study (HEN) Kate Farms Peptide 1.5, Crohn's disease exclusion diet - Enteral Nutrition's Effect on the Gut | Not applicable | Recruiting | James Lewis | 25 | 2026-06-17 | 2026-08-06 |
| Controlled Feeding Experiment High fat diet - Effect of Diet on Microbiome Composition | Not applicable | Completed | James Lewis | 10 | 2009-07-01 | 2013-06-25 |
| Dose Escalation and Remission (DEAR) mesalamine - Ulcerative Colitis | Phase 4 | Completed | James Lewis | 119 | 2008-09-01 | 2015-05-05 |
| Gene Regulation by Thiazolidinediones Rosiglitazone - Inflammatory Bowel Disease | Phase 4 | Completed | James Lewis | 12 | 2007-10-01 | 2016-08-01 |
| A Trial of Rosiglitazone for Ulcerative Colitis Rosiglitazone, Placebo - Ulcerative Colitis, Inflammatory Bowel Disease | Phase 2 | Completed | James Lewis | 105 | 2002-09-01 | 2018-01-16 |
Inflammatory Bowel Diseases (3) · Colitis, Ulcerative (2) · Colitis (1) · Ulcer (1)
Rosiglitazone (2) · Diet, High-Fat (1) · Mesalamine (1)
United States (5)
PMID 18325386, PMID 18623174, PMID 24793028
R01DK059961 (2), K24DK078228 (1), UH2DK083981 (1)